CN1040433C - 唑类化合物及其生产方法和应用 - Google Patents

唑类化合物及其生产方法和应用 Download PDF

Info

Publication number
CN1040433C
CN1040433C CN93105239A CN93105239A CN1040433C CN 1040433 C CN1040433 C CN 1040433C CN 93105239 A CN93105239 A CN 93105239A CN 93105239 A CN93105239 A CN 93105239A CN 1040433 C CN1040433 C CN 1040433C
Authority
CN
China
Prior art keywords
compound
phenyl
salt
difluorophenyl
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN93105239A
Other languages
English (en)
Chinese (zh)
Other versions
CN1079467A (zh
Inventor
伊藤克己
小此木研二
田村典一
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of CN1079467A publication Critical patent/CN1079467A/zh
Application granted granted Critical
Publication of CN1040433C publication Critical patent/CN1040433C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polymerization Catalysts (AREA)
  • Coloring (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)
  • Lubricants (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN93105239A 1992-04-28 1993-04-28 唑类化合物及其生产方法和应用 Expired - Fee Related CN1040433C (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP11040092 1992-04-28
JP110400/92 1992-04-28
JP2262393 1993-02-10
JP22623/93 1993-02-10

Publications (2)

Publication Number Publication Date
CN1079467A CN1079467A (zh) 1993-12-15
CN1040433C true CN1040433C (zh) 1998-10-28

Family

ID=26359882

Family Applications (1)

Application Number Title Priority Date Filing Date
CN93105239A Expired - Fee Related CN1040433C (zh) 1992-04-28 1993-04-28 唑类化合物及其生产方法和应用

Country Status (18)

Country Link
US (2) US5371101A (OSRAM)
EP (1) EP0567982B1 (OSRAM)
JP (1) JP2818097B2 (OSRAM)
KR (1) KR100257619B1 (OSRAM)
CN (1) CN1040433C (OSRAM)
AT (1) ATE167857T1 (OSRAM)
AU (1) AU655544B2 (OSRAM)
CA (1) CA2094962A1 (OSRAM)
DE (1) DE69319380T2 (OSRAM)
DK (1) DK0567982T3 (OSRAM)
ES (1) ES2118160T3 (OSRAM)
FI (1) FI931901A7 (OSRAM)
HU (2) HUT64327A (OSRAM)
NO (1) NO303284B1 (OSRAM)
NZ (1) NZ247488A (OSRAM)
PH (1) PH31082A (OSRAM)
SG (1) SG48939A1 (OSRAM)
TW (1) TW218017B (OSRAM)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU212458B (en) * 1993-09-23 1996-06-28 Richter Gedeon Vegyeszet New silyloxypropane derivatives substituted with triazole or imidazole pharmaceutical compositions containing them and process for producing them
TW297813B (OSRAM) * 1993-09-24 1997-02-11 Takeda Pharm Industry Co Ltd
CA2134417A1 (en) * 1993-12-22 1995-06-23 Katsumi Itoh Optically active azole derivatives, their production and use
NZ270418A (en) * 1994-02-07 1997-09-22 Eisai Co Ltd Polycyclic triazole & imidazole derivatives, antifungal compositions
EP0746318A1 (en) * 1994-02-25 1996-12-11 Takeda Chemical Industries, Ltd. Injectable emulsions containing antifungal triazole derivatives
US5677464A (en) * 1994-05-31 1997-10-14 Takeda Chemical Industries, Ltd. Production of optically active triazole compounds and their intermediates
US5639754A (en) * 1994-07-12 1997-06-17 Janssen Pharmaceutica N.V. Urea and thiourea derivatives of azolones
US5637592A (en) * 1994-07-12 1997-06-10 Janssen Pharmaceutica N.V. Acyl derivatives of azolones
TW318841B (OSRAM) 1995-02-17 1997-11-01 Takeda Pharm Industry Co Ltd
CA2211458A1 (en) * 1995-02-17 1996-08-22 Kenji Okonogi Azole compounds, their production and use
US6060604A (en) 1995-03-31 2000-05-09 Florida State University Pharmaceutical compounds comprising polyamines substituted with electron-affinic groups
US5700825A (en) * 1995-03-31 1997-12-23 Florida State University Radiosensitizing diamines and their pharmaceutical preparations
DE19520597A1 (de) * 1995-06-06 1996-12-12 Bayer Ag Mercapto-bis-triazole
MX9702382A (es) * 1995-08-02 1998-02-28 Uriach & Cia Sa J Nuevos derivados de pirimidona con actividad antifungica.
WO1997005131A1 (en) * 1995-08-02 1997-02-13 J. Uriach & Cia. S.A. New carboxamides with antifungal activity
ES2120885B1 (es) * 1996-03-15 1999-06-16 Uriach & Cia Sa J Nuevas tienopirimidonas con actividad antifungica.
ES2107376B1 (es) * 1995-08-02 1998-07-01 Uriach & Cia Sa J Nuevos derivados de pirimidona con actividad antifungica.
GB9602080D0 (en) 1996-02-02 1996-04-03 Pfizer Ltd Pharmaceutical compounds
US6001835A (en) * 1996-04-03 1999-12-14 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
CA2250353A1 (en) * 1996-04-03 1997-10-09 Christopher J. Dinsmore Inhibitors of farnesyl-protein transferase
AU6119798A (en) * 1997-03-05 1998-09-22 Takeda Chemical Industries Ltd. Crystalline form of a bis 1,2,4-triazole compound
AU6520098A (en) 1997-03-31 1998-10-22 Takeda Chemical Industries Ltd. Azole compounds, their production and their use
EP0884311A3 (en) * 1997-06-06 1999-01-27 Takeda Chemical Industries, Ltd. Triazole Derivatives and their production
US6133485A (en) * 1998-04-15 2000-10-17 Synphar Laboratories, Inc. Asymmetric synthesis of 2-(2,4-difluorophenyl)-1-heterocycl-1-yl butan-2,3-diols
WO2000018401A1 (fr) * 1998-09-29 2000-04-06 Takeda Chemical Industries, Ltd. Composition de medicament antimycotique
NZ521241A (en) * 2000-03-07 2004-02-27 Ranbaxy Lab Ltd Azole compounds as therapeutic agents for fungal infections
IN191188B (OSRAM) 2000-03-07 2003-10-04 Ranbaxy Lab Ltd
ES2159488B1 (es) * 2000-03-07 2002-04-16 Uriach & Cia Sa J Procedimiento para la preparacion de derivados de pirimidona con actividad antifungica.
MXPA03005899A (es) 2000-12-26 2004-01-26 Ranbaxy Lab Ltd Compuestos azoles como agentes anti-micoticos.
JP2004524348A (ja) * 2001-03-23 2004-08-12 リチュテル・ゲデオン・ヴェジェーセティ・ジャール・エルテー フルコナゾールおよびその結晶変形の製造方法
IN191819B (OSRAM) * 2001-07-19 2004-01-03 Ranbaxy Lab Ltd
IN192526B (OSRAM) * 2001-09-25 2004-04-24 Ranbaxy Lab
US7028055B2 (en) * 2002-03-22 2006-04-11 Sun Microsystems, Inc. Method and apparatus for improving transaction specification by marking application states
US20050261330A1 (en) * 2002-04-12 2005-11-24 Mohammad Salman Derivatives of 2,2,4-trisubstituted tetrahydrofuran an antifungal agents
ATE521349T1 (de) 2002-06-18 2011-09-15 Pola Pharma Inc Antimykotische medizinische zusammensetzungen
WO2004018485A1 (en) * 2002-08-26 2004-03-04 Ranbaxy Laboratories Limited Azole derivatives as antifungal agents
KR100572996B1 (ko) * 2003-08-12 2006-04-25 한국화학연구원 불소화 비닐 에테르 측쇄기를 갖는 아졸계 살균제 화합물및 그의 제조방법
ME01498B (me) 2004-11-18 2014-04-20 Synta Pharmaceuticals Corp Jedinjenja triazola koja modulišu aktivnost hsp90
CN1304376C (zh) * 2005-03-04 2007-03-14 清华大学 一种卤化烷基咪唑型离子液体的制备方法
AU2006279794B2 (en) * 2005-08-12 2011-04-07 Synta Pharmaceuticals Corp. Pyrazole compounds that modulate HSP90 activity
TWI446910B (zh) * 2005-08-18 2014-08-01 Synta Pharmaceuticals Corp 調節hsp90活性的三唑化合物
US20080027047A1 (en) * 2006-05-25 2008-01-31 Weiwen Ying Compounds that modulate HSP90 activity and methods for identifying same
US8318790B2 (en) * 2006-05-25 2012-11-27 Synta Pharmaceuticals Corp. Triazole compounds that modulate HSP90 activity
CA2653329C (en) 2006-05-25 2018-01-16 Synta Pharmaceuticals Corp. Triazole compounds that modulate hsp90 activity
EP2038262B1 (en) * 2006-05-25 2014-11-12 Synta Pharmaceuticals Corp. Triazole compounds that modulate hsp90 activity
ES2652670T3 (es) 2006-08-07 2018-02-05 Palau Pharma, S.A. Compuestos antifúngicos cristalinos
CA2666489C (en) * 2006-10-19 2012-10-02 F. Hoffmann-La Roche Ag Imidazolone and imidazolidinone derivatives as 11b-hsd1 inhibitors for diabetes
US9205086B2 (en) 2010-04-19 2015-12-08 Synta Pharmaceuticals Corp. Cancer therapy using a combination of a Hsp90 inhibitory compounds and a EGFR inhibitor
CN102824342B (zh) * 2011-06-17 2016-03-30 全哲山 一类用作抗癫痫药的化合物及其可药用盐
CA2853799A1 (en) 2011-11-02 2013-05-10 Synta Pharmaceuticals Corp. Cancer therapy using a combination of hsp90 inhibitors with topoisomerase i inhibitors
WO2013067165A1 (en) 2011-11-02 2013-05-10 Synta Pharmaceuticals Corp. Combination therapy of hsp90 inhibitors with platinum-containing agents
US9402831B2 (en) 2011-11-14 2016-08-02 Synta Pharmaceutical Corp. Combination therapy of HSP90 inhibitors with BRAF inhibitors

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4625036A (en) * 1983-03-08 1986-11-25 Imperial Chemical Industries Plc Antifungal azole compounds
US4925863A (en) * 1984-09-05 1990-05-15 Imperial Chemical Industries Plc Antifugal azole compounds
US5126359A (en) * 1988-11-04 1992-06-30 Bayer Aktiengesellschaft Substituted bisazoles and their use as medicaments

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK159205C (da) * 1983-03-16 1991-03-04 Pfizer Bis(triazol)alkanol-forbindelser, anvendelse af disse, farmaceutiske praeparater og landbrugsfungicider indeholdende disse og fremgangsmaade til behandling af planter eller froe, som har en svampeinfektion
NZ223799A (en) * 1987-03-25 1989-12-21 Janssen Pharmaceutica Nv Azolylmethyl-dioxolanylmethoxyphenyl-piperazinyl-phenyl-triazolones and antimicrobial compositions
NO171272C (no) * 1988-03-04 1993-02-17 Sankyo Co Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2,4-triazolforbindelser

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4625036A (en) * 1983-03-08 1986-11-25 Imperial Chemical Industries Plc Antifungal azole compounds
US4925863A (en) * 1984-09-05 1990-05-15 Imperial Chemical Industries Plc Antifugal azole compounds
US5126359A (en) * 1988-11-04 1992-06-30 Bayer Aktiengesellschaft Substituted bisazoles and their use as medicaments

Also Published As

Publication number Publication date
KR100257619B1 (en) 2000-07-01
ES2118160T3 (es) 1998-09-16
KR940005616A (ko) 1994-03-21
TW218017B (OSRAM) 1993-12-21
JP2818097B2 (ja) 1998-10-30
JPH06293740A (ja) 1994-10-21
US5371101A (en) 1994-12-06
NO931533L (no) 1993-10-29
FI931901L (fi) 1993-10-29
FI931901A7 (fi) 1993-10-29
NZ247488A (en) 1995-02-24
EP0567982B1 (en) 1998-07-01
DE69319380D1 (de) 1998-08-06
SG48939A1 (en) 1998-05-18
FI931901A0 (fi) 1993-04-27
HU9301226D0 (en) 1993-07-28
NO303284B1 (no) 1998-06-22
DE69319380T2 (de) 1998-10-29
ATE167857T1 (de) 1998-07-15
US5466820A (en) 1995-11-14
EP0567982A1 (en) 1993-11-03
CA2094962A1 (en) 1993-10-29
HUT64327A (en) 1993-12-28
CN1079467A (zh) 1993-12-15
AU655544B2 (en) 1994-12-22
PH31082A (en) 1998-02-05
HU211474A9 (en) 1995-11-28
DK0567982T3 (da) 1999-04-12
NO931533D0 (no) 1993-04-27
AU3822193A (en) 1993-11-04

Similar Documents

Publication Publication Date Title
CN1040433C (zh) 唑类化合物及其生产方法和应用
CN1185230C (zh) N-取代的氨基甲酰氧基烷基-吡咯鎓衍生物
CN1072680A (zh) 旋光吡咯化合物及其制法和用途
CN1291985C (zh) 促进神经营养蛋白产生/分泌的药剂
CN1078444C (zh) 含硅的杀真菌化合物、其制备方法及其在农业化学和医药上的应用
CN1255401C (zh) 芳基-哌嗪衍生物、及其制备和作为速激肽拮抗剂的应用
CN1103770C (zh) 喹喔啉二酮化合物
CN1036304C (zh) 以苯基三唑衍生物作为活性成份的杀虫剂组合物
CN1106390A (zh) 吡咯化合物,其生产及应用
CN1197849C (zh) 作为基质金属蛋白酶抑制剂的2,3,4,5-四氢-1h-[1,4]苯并二氮杂草-3-异羟肟酸
CN1074413C (zh) 具有cgmp-磷酸二酯酶抑制活性的新苯并咪唑衍生物
CN1060841A (zh) 喹唑啉衍生物及其制备方法
CN1575284A (zh) 作为激酶抑制剂的取代的三唑二胺衍生物
CN1073944A (zh) 三取代四氢呋喃抗真菌剂
CN1035817C (zh) 三唑基取代的叔胺化合物及其盐的制备方法
CN1155599C (zh) 三环三唑并苯并氮杂�衍生物、用于制备该衍生物的方法和抗变态反应剂
CN1473160A (zh) 抗真菌和/或抗寄生虫的药物组合物以及作为该组合物活性组分的新的吲哚衍生物
CN101031555A (zh) 具有vap-1抑制活性的噻唑衍生物
CN1639133A (zh) 新抗菌化合物、其制备方法和含有它们的药物组合物
CN1291979C (zh) 咪唑化合物及其作为腺苷脱氨酶抑制剂的用途
CN1922156A (zh) 作为钠通道阻断剂的取代的三唑
CN1059336A (zh) 抗真菌的三唑衍生物及其制备和用途
CN1151138C (zh) 三唑抗真菌剂
CN1175950A (zh) 唑系化合物、其制备及用途
CN1040366A (zh) 丁烯酸或丙烯酸衍生物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee